The downregulation of Brain-type creatine kinase (CKB) is well described in HD mouse models and human patients (Mochel et al., 2012; Lin et al., 2013), where mHtt is known to lower somatic CKB expression in primary neurons and striatum of HD mice (Lin et al., 2013). The gene discussed is CKB; the disease is Huntington disease.